Sign in
CompletedNo phase

Comparison of Target-Controlled and Manual Total Intravenous Anesthesia in Supratentorial Surgery

Key facts

Who runs it
Istanbul University - Cerrahpasa
Where
Türkiye2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
63 people enrolled
Started
14 Jan 2026
Ended
16 Jul 2026
Type of study
Interventional, 2 groups
Treatments tested
  • Target Controlled Infusion
  • Total Intravenous Anesthesia(TIVA)
Record updated
9 September 2026

Who can take part

Age
18 years to 60 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Adult patients aged 18 to 60 years
  • Scheduled for elective supratentorial surgery under general anesthesia
  • American Society of Anesthesiologists (ASA) physical status I or II
  • Planned total intravenous anesthesia with propofol and remifentanil
  • Ability to provide written informed consent

Who cannot take part

  • Emergency surgery
  • Intraoperative deviation from the study protocol, including changes in surgical or anesthetic technique or occurrence of major intraoperative complications
  • Inability to communicate effectively (e.g., non-Turkish speaking or hearing impairment)
  • Preoperative risk factors for delirium, including substance abuse, use of neuropsychiatric medications, preoperative hemoglobin level < 8 g/dL, malnutrition, or electrolyte or thyroid hormone abnormalities
  • Refusal or inability to provide written informed consent
  • American Society of Anesthesiologists (ASA) physical status III or higher
  • Pregnancy
  • Presence of brain herniation
  • Anticipated or documented difficult airway
  • Contraindications to propofol or remifentanil

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aims to investigate the effect of target-controlled infusion using the Eleveld pharmacokinetic model compared with manually controlled total intravenous anesthesia on the incidence of postoperative delirium in patients undergoing supratentorial surgery. Propofol and remifentanil are administered using either target-controlled or manual infusion techniques according to the study protocol. Secondary objectives include comparisons of intraoperative anesthetic consumption, hemodynamic responses, recovery profiles, postoperative pain, and postoperative nausea and vomiting between the two anesthesia strategies. The study seeks to evaluate whether target-controlled infusion provides improved anesthetic management and postoperative outcomes compared with manual total intravenous anesthesia.

The 2 groups in the trial

  • Manual Total Intravenous AnesthesiaTreatment being tested

    Participants receive manually controlled total intravenous anesthesia using propofol and remifentanil, with dosing adjusted by the anesthesiologist based on clinical parameters and bispectral index monitoring.

    Treatment: Total Intravenous Anesthesia(TIVA)

  • Target-Controlled Infusion (TCI)Treatment being tested

    Participants receive target-controlled infusion of propofol and remifentanil using the Eleveld pharmacokinetic model, with effect-site targeting throughout the surgical procedure.

    Treatment: Target Controlled Infusion

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Comparison of Target-Controlled Infusion Using the Eleveld Model and Manual Total Intravenous Anesthesia on Intraoperative Anesthetic Consumption and Postoperative Pain and Delirium in Supratentorial Surgery
Record updated
9 September 2026